Indomethacin treatment decreases renal blood flow velocity in human neonates

Biology of the Neonate

Volumn 76, Issue 5, 1999, Pages 261-265

  Kang, Nam Soo ^a   Yoo, Kee Hwan ^a,b   Cheon, Haewon ^a   Choi, Byung Min ^a   Hong, Young Sook ^a   Lee, Joo Won ^a   Kim, Soon Kyum ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Indomethacin; Neonates; Patent ductus arteriosus; Renal dysfunction

Indexed keywords

CREATININE; INDOMETACIN; INDOMETACIN MEGLUMINE; SODIUM;

ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY PERFUSION; MALE; NEWBORN; OSMOLARITY; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; RENAL ARTERY; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; URINARY EXCRETION; URINE VOLUME;

BIRTH WEIGHT; BLOOD FLOW VELOCITY; CREATININE; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFUSIONS, INTRAVENOUS; KIDNEY DISEASES; MALE; OSMOLAR CONCENTRATION; PROSPECTIVE STUDIES; RENAL ARTERY; RENAL CIRCULATION; SODIUM; ULTRASONOGRAPHY, DOPPLER, COLOR; URINATION;

EID: 0032849132     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014167     Document Type: Article

References (10)

1. Siassi B, Blanco C, Cabal LA, Coran AG: Incidence and clinical features of patent ductus arteriosus in low-birth weight infants: A prospective analysis of 150 consecutively born infants. Pediatrics 1976;57: 347-351.
2. Gersony WM, Pekham GJ, Ellison RC: Effects of indomethacin in preamture infants with patent ductus arteriosus. Results of a national collaborative study. J Pediatr 1983; 102:895-906.
3. Merritt TA, Corazza RB, Ikonen RS, Davis R, Rosenberg M: Clinical trials of intravenous indomethacin for closure of the patient ductus arteriosus. Pediatr Cardiol 1983;4 (suppl 2):71-79.
4. Barrington KJ, Fox M: Predicting oliguria following indomethacin for treatment of patent ductus arteriosus. Am J Perinatol 1994;11:220-222.
5. Van Bel F, Guit GL, Schipper J, Van de Bor M, Baan J: Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 1991;118: 621-626.
6. Chemtob S, Beharry K, Rex J: Ibuprofen enhances retinal and choroidal blood flow autoregulation in newborn piglets. Invest Ophthalmol Vis Sci 1991;32:1799-1807.
7. Berl T, Raz A, Wald H: Prostaglandin synthesis inhibition and the action vasopressin: Studies in man and rats. Am J Physiol 1977;232: 529-533.
8. Cleary GM, Higgins ST, Merton DA, Cullen JA, Gottlieb RP, Baumgart S: Developmental changes in renal artery blood flow velocity during the first three weeks of life in preterm neonates. J Pediatr 1996;129: 251-257.
9. Lin YJ, Tsai YJ, Chen JS, Lin JS, Wu JM, Lin CH, Yeh TF: Renal effects and urinary excretion of prostaglandin following indomethacin therapy in premature infants with patent ductus arteriosus. Acta Paediatr Sin 1995;36:104-107.
10. Lieberthal W, Koh JS, Levine JS: Necrosis and apoptosis in acute renal failure. Semin Nephrol 1998;18: 505-518.